From preclinical and animal models, it has been hypothesized that autoimmune responses against GAD in pancreatic islet deplete this enzyme and reduce GABA levels within the GABAergic system in the endocrine pancreas, thus promoting the progression of T1D. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.